- Home
- LTH vs INM Comparison
LTH vs INM Comparison
Compare LTH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTH
- INM
- Stock Information
- Founded
- LTH 1992
- INM 1981
- Country
- LTH United States
- INM Canada
- Employees
- LTH N/A
- INM N/A
- Industry
- LTH Hotels/Resorts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LTH Consumer Discretionary
- INM Health Care
- Exchange
- LTH Nasdaq
- INM Nasdaq
- Market Cap
- LTH 6.3B
- INM 3.2M
- IPO Year
- LTH 2021
- INM N/A
- Fundamental
- Price
- LTH $29.23
- INM $2.90
- Analyst Decision
- LTH Buy
- INM
- Analyst Count
- LTH 13
- INM 0
- Target Price
- LTH $34.42
- INM N/A
- AVG Volume (30 Days)
- LTH 4.3M
- INM 5.7M
- Earning Date
- LTH 07-31-2025
- INM 05-12-2025
- Dividend Yield
- LTH N/A
- INM N/A
- EPS Growth
- LTH 174.52
- INM N/A
- EPS
- LTH 0.96
- INM N/A
- Revenue
- LTH $2,730,319,000.00
- INM $4,920,990.00
- Revenue This Year
- LTH $14.61
- INM N/A
- Revenue Next Year
- LTH $11.38
- INM N/A
- P/E Ratio
- LTH $30.41
- INM N/A
- Revenue Growth
- LTH 18.58
- INM N/A
- 52 Week Low
- LTH $18.53
- INM $1.72
- 52 Week High
- LTH $34.99
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- LTH 51.11
- INM 50.30
- Support Level
- LTH $28.87
- INM $2.93
- Resistance Level
- LTH $30.51
- INM $5.50
- Average True Range (ATR)
- LTH 0.96
- INM 0.36
- MACD
- LTH 0.17
- INM 0.01
- Stochastic Oscillator
- LTH 73.88
- INM 22.22
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.